Connect with us

Health

Medical Marijuana Relieves Chronic Pain; Here is How!

Published

on


The cannabis plant or its chemical constituents are used in medical marijuana to treat illnesses or conditions. Although used for medical reasons, it is essentially the same product as marijuana used for recreational purposes. There are more than 100 distinct cannabinoids in marijuana plants. Each one uniquely affects the body. The two major substances found in cannabis—cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC)—are employed in medicine. THC is also responsible for the “high” that results from marijuana consumption or smoking.

Medical marijuana can help in several conditions, such as the following:

Alzheimer’s condition, hunger loss, Cancer, Crohn’s illness, Immune system-compromising conditions including HIV/AIDS and Multiple Sclerosis (MS), problems of eating such as anorexia, Epilepsy, Glaucoma, Posttraumatic stress disorder (PTSD), schizophrenia, spasms of muscles, nausea and pain. Most of the research on cannabis’ therapeutic benefits focuses on its capacity to lessen chronic pain.

According to a recent study, non-psychoactive cannabinoids like CBD, marijuana, and others can be used to effectively prevent and cure GI diseases like Crohn’s disease, ulcerative colitis, IBS, and more. The anti-inflammatory effects of CBD are essential for treating and avoiding symptoms. In addition to being used to lessen the side effects of chemotherapy, studies have shown that CBD has several anti-cancer properties that can help prevent a wide range of cancers, treat tumors, and strengthen the immune system. It has also been shown to stop cell growth and induce cell death in cervical cancer cell lines.

Medical Marijuana and Chronic Pain

It is possible to date the usage of medical marijuana to more than 5000 years ago. Early Chinese doctors used it to alleviate rheumatic pain, malaria, constipation, and even discomfort from delivery. Cannabis used medicinally, as specified in the United States Pharmacopoeia, was commonly utilized in the 19th and 20th centuries. Under the terms of the Compassionate Usage Act, California became the first state to legalize marijuana use when it was done so in 1996. Numerous studies on the efficiency of medicinal cannabis in treating chronic pain have been conducted over a long period. One such study examined the opinions of people with chronic pain toward medical marijuana.

The 984 individuals with chronic pain included in the study had neuropathic pain, back pain, arthritis, post-surgical pain, headaches, and stomach pain, among other types of pain. Two-thirds of the participants in this study indicated that the primary advantage of marijuana use was pain alleviation. The second most frequently mentioned benefit was helping with sleep. A 64% decrease in opiate use was also observed among chronic pain patients who used medical marijuana, according to another study. These patients’ quality of life increased and their adverse effects decreased.

Cannabis medicine has gained importance as a potential alternative therapy because of the ongoing opiate epidemic. Cannabis does not produce respiratory depression, unlike opioids, which results in lower fatality rates. Thus, Medical Marijuana plays a very important role in relieving Chronic Pain and many such problems. The easy way to get medical marijuana is by getting a Medical Marijuana Card.

Medical Marijuana Card

A medical cannabis card, also known as a medical marijuana card, is a state-issued identification document that permits a patient with a prescription from a doctor to buy, keep, or grow cannabis for medicinal purposes. Medical marijuana is legalized by a majority of states. Every state has different laws regarding the use of medical marijuana. Some states permit recreational use as well. In order to use medical marijuana, patients have to obtain a medical cannabis license or medical marijuana card from the state in which they reside.

These licenses are given out by a state or county that has legalized medical marijuana. Before applying for a medical marijuana card with the state, a patient should have a recommendation from a state-licensed physician. Usually, to receive a medical marijuana card, a patient must pay a fee to the state. Some states even allow patients to grow a limited number of cannabis plants at home. Different states have different processes for application which can be found on the website of the respective state. Alternative terms for it include medical marijuana identification (MMID) and medical marijuana (MMJ). 

How to get Medical Marijuana Card online

The quickest and most practical way to register to possess marijuana for medical purposes is to get a medical marijuana card online. The process is divided into the following easy steps:

Step 1: Patients register online to get evaluated by a doctor. They pay the doctor’s consultation fee and set an appointment. The doctor evaluates them over a phone call or a video call and if approved, provides them with a recommendation. The recommendation has to be renewed annually. In some states such as California, the doctor’s recommendation is enough to buy products at the dispensary. In other states, you have to follow step 2.

Step 2: Patients use the doctor’s recommendation to register with the state medical marijuana program.  Every state has a dedicated website for its medical marijuana program. In most cases, the patient has to state-fee to get the marijuana card. Every state has some basic requirements including proof of identity, proof of residence, and a recommendation by a state-licensed doctor. When a patient fulfills all these requirements, the state issues him/her a medical marijuana card. In most cases, the state first provides a temporary card in the email which is followed by a regular card in the mail. In most states, the card has to be renewed annually.  

Step 3: Buy products at a dispensary.

Bottom Line

Medical marijuana is a natural remedy for most of the illnesses prevailing today. It can help relieve chronic pain and mental health conditions. The risk of probable side effects from overconsumption can be decreased by adhering to the recommended dosage and usage. Only buy edible cannabis products from a reputable registered dispensary if you’re in a state where doing so is permitted. For first-time customers, the range of cannabis products available in dispensaries, each with a distinct level of THC and CBD, might be confusing. The doctor’s instructions and dosage limits should always be followed. Telemedicine has made the process of obtaining a medical marijuana card a lot easier. With a few clicks, you can set an appointment, talk to the doctor and get your recommendation. So get your recommendation today and give nature’s medicine a chance to heal you!

Online Medical Card Team



Source link

gateway-drug

Weed is not a gateway drug, says new study

Published

on

By


In a study published earlier this month, researchers help dispel the idea of cannabis as a gateway drug—a substance that leads to the use of other harder drugs. It shows that when a state legalizes weed, it does not lead to adults using other substances, nor an increase in substance abuse, either with cannabis or other substances. In fact, the study found that legalization may lead to a decrease in alcohol-related problems.

The theory of cannabis as a gateway drug came about in the 1970s, wrapped up in the messaging of the War on Drugs, a campaign that ostensibly tries to curb drug usage in the US, but ultimately targets people of color for mass incarceration (and still does today). 

The theory suggests that cannabis and alcohol are “soft” drugs that are easy to get—especially for teens—and that doing them will lead to hard drugs, such as cocaine, heroin, and others, as well as addiction.

Prohibitionists have long touted cannabis as a gateway drug in order to block legalization efforts across the country. This study helps to debunk the false narrative on weed, and gives weight to the pro-legalization movement.

“We really didn’t find any support for a lot of the harms people worry about with legalization,” said lead author Stephanie Zellers in a press release. “From a public health perspective, these results are reassuring.”

Related

The history of cannabis prohibition in the United States

What does the study say?

Pulling data from two decades-long studies at The University of Colorado and The University of Minnesota, the study looked at over 4,000 twins—40% in a state with legal recreational weed (Colorado) and 60% in a state without legal cannabis (Minnesota). The use of twins in the study “controls for a wide range of variables, including age, social background, early home life, and even genetic inheritance,” said author John Hewitt.

Subjects were studied at two different points: before 2014, when Colorado first opened dispensaries, and after. It measured for alcohol, tobacco, cannabis, and illicit substance usage, as well as mental health.

“For low-level cannabis use, which was the majority of users, in adults, legalization does not appear to increase the risk of substance use disorders,” said co-author Dr. Christian Hopfer. This was the case for both cannabis and other substances.

The study also found no connection between legalization and cognitive, psychological, social, relationship or financial problems in individuals.

It went on to say that prevention and intervention of cannabis abuse would be best targeted on risk factors, such as family history, mental health disorders, etc., rather than the availability of cannabis.

It’s important to note that the study was limited in some capacities in that it only focuses on individuals in Minnesota and Colorado, and that 92% of participants were white. Additionally, subjects were “characterized by low levels of substance use and psychosocial dysfunction,” according to the study.

Related

Is marijuana a ‘Gateway Drug’?

Why this study is important

Although the idea of cannabis as a gateway drug is becoming more of a relic, continuing to dispel the idea can lead to more states legalizing cannabis for recreational use, and eventually, the federal government. 

With legalization comes regulation and product testing, an essential step to ensure that consumers know what’s in their cannabis products, something that doesn’t happen with illicit market products. Legalization will also lead to more research on the plant to more fully understand its benefits and effects.  

The study authors note that although legalization does not lead to substance abuse disorders, either with cannabis or another substance, more research is needed on the plant, in particular, on THC potency, dosage, and consumption patterns. 

Pat Goggins's Bio Image

Pat Goggins

Pat Goggins is a senior editor who handles Leafly’s informational content and specializes in cannabis cultivation after working for a commercial grower in Oregon. When not fixing typos, you’ll probably find him on a boat or in the mountains.

View Pat Goggins’s articles



Source link

Continue Reading

All about Cannabis

Health Canada: Let’s Ban Potent Cannabis Extracts  – Cannabis | Weed | Marijuana

Published

on

By


Despite a healthcare system already on the verge of collapse pre-COVID, Health Canada bureaucrats have focused on cannabis companies selling extracts.

Health Canada recently requested federally licensed cannabis companies to discontinue the sale of cannabis products the bureaucracy considers mislabeled. Health Canada is concerned adults are consuming products labelled “extracts” as “edibles.”

The move is expected to cost cannabis companies millions of dollars. And it comes at a time when most publicly traded cannabis producers are still losing money.

Why target products that have been on the market for three years? Health Canada has not responded to any media on the topic, including Cannabis Life Network’s request for clarification.

Health Canada: Let's Ban Cannabis Extracts 

While Health Canada’s targeting of cannabis extracts surprises many, others, like CLN, have been expecting this move for a while.

In the letter seen by MJBizDaily, Health Canada said that “upon further review of the products in question, Health Canada has assessed that this product is edible cannabis and, consequently, it contains a quantity of THC that exceeds the allowable limit of 10 mg per immediate container.”

The letter goes on to define “extract,” “edible,” and “food.”

“Health Canada has determined that (the products in question) are consumed in the same manner as food, and therefore fit the definition of edible cannabis,” the Health Canada letter says.

Cannabis extracts cannot exceed 1,000 milligrams per container, one hundred times more than Health Canada permits in the edible class. Ergo, companies would instead produce extracts than edibles.

However, the line has gotten blurred, and this is likely what concerns the bureaucracy’s busybodies. For example, New Brunswick-based cannabis producer Organigram has a “Jolts” product advertised as a lozenge. While each candy is 10mg, the entire pack of 100mg.

Likewise, Redecan has a cannabis extract containing 800 to 1000mg of THC per bottle. However, the oral dispensing syringe caps each “dose” at 8-10mg. 

Are these the products Health Canada wants discontinued?

Health Canada On Extracts: Useless

Health Canada: Let's Ban Cannabis Extracts 

Why Health Canada? And why now? Why at all?

Industry sources expect to lose tens of millions if Health Canada demands extracts and lozenges get pulled from the Canadian cannabis market. They also expect the illicit and legacy markets to fill the void.

Regardless of what you think about public health and safety or an individual’s freedom to consume as much THC as they want, there’s significant concern about how Health Canada is going about this.

This kind of regulatory enforcement is akin to banana republics. Health Canada has already approved these products. Organigram’s “Jolts” have been on the market for over a year.

Producers of these extracts followed all the rules and regulations. And now Health Canada will arbitrarily limit (or ban) these products because… what? Canadian consumers prefer potent extracts over weak-ass edibles?

The lesson here is to remove all THC limits, not bring the hammer down on companies producing legal products. This is not how you regulate an industry.

Infantilizing Adults

While Health Canada hasn’t responded to a request for comment, I suspect the justification will likely be over “public health” and “increased hospitalizations from high-THC products.”

Another way of saying: we’re so bad at delivering health care that instead of improving it, we’re going to start controlling the behaviours that may lead people to need a hospital bed.

That’s the most insulting part of all of this. Health Canada treats adult cannabis consumers like children by limiting their autonomy and decision-making.

Actions speak louder than words. Health Canada bureaucrats (who live off our taxes) lack trust in cannabis-consuming adults to make their own choices and take responsibility for their actions.

When regulations are not based on evidence or are not well-reasoned, they are an infringement on personal liberty and autonomy.

Even with “conventional thinking,” in which government regulations are effective and immune to corruption and politics, it’s essential that regulators balance the need to protect public health and safety with the need to respect adults’ autonomy and decision-making abilities.

Health Canada’s crackdown on cannabis extracts clearly violates that balance. 

This situation would be like if Health Canada discovered that vodka and whiskey were stronger than beer. And so they order distilleries across the nation to arbitrarily limit their alcohol content and take the products off the shelves.

Health Canada has no business regulating cannabis. 

Footnote(s)





Source link

Continue Reading

All about Cannabis

10 Ways Most Cannabis Research is False – Cannabis | Weed | Marijuana

Published

on

By


Most cannabis research is false. A bold statement. So what does it mean? In 2005, Stanford University professor John Ioannidis published the paper “Why Most Published Research Findings Are False.”

In it, he argued that most published research findings are false due to a combination of factors such as small sample sizes, inadequate adjustment for multiple comparisons, and conflicts of interest.

The paper made quite an uproar in the scientific community. While some criticized Ioannidis for simplifying the problem, most agree there is a replication crisis in scientific literature. For example, one study may find cannabis increases the risk of heart attacks. But if no other research can replicate its findings, is the study telling us anything authentic or valid?

The replication crisis doesn’t only affect sociology, medicine or psychology. It also affects cannabis studies. Leading to an uncomfortable conclusion: most cannabis research is false. 

Most Cannabis Research is False

Most Cannabis Research is False

Is most cannabis research false? The replication crisis has led to calls for more transparency and rigour in the research process. But ultimately, the only way out is to evaluate studies based on their replication rate.

Can adolescent cannabis use lead to psychosis or an increased risk of developing schizophrenia? Are cannabis consumers less likely to abuse opioid-based pain medication? Does cannabis make you a more compassionate person? Can it lead to poor cardiovascular health? Will cannabis impair your driving?

Some studies answer in the affirmative, others in the negative. Prohibitionists and public health busybodies like to cite studies that show cannabis’ negative qualities. Proponents of cannabis tend to mention the positive studies.

But most cannabis research is false, whether it confirms your bias or not.

10 Ways Most Cannabis Research is False

The replication crisis has affected studies on cannabis in several ways, including:

  1. Lack of replication: Many studies on cannabis have been criticized for their inability to be replicated. This calls into question the validity of their findings.
  2. Lack of standardization: There is a lack of standardization in the way cannabis is used and administered in studies (not to mention the strains used, their specific cannabinoid content, etc.). This makes it impossible to compare results across different studies.
  3. Small sample sizes: Many studies on cannabis have small sample sizes, which can lead to unreliable results.
  4. Lack of control groups: Some studies on cannabis have lacked proper control groups. This makes it difficult to determine the specific effects of cannabis.
  5. Uncontrolled variables: Many studies on cannabis have not controlled for other factors that could affect the results, such as tobacco use or poor diet. Sometimes, researchers won’t even account for underlying medical conditions.
  6. Limited generalizability: Some researchers conduct studies on cannabis on specific populations, such as patients with a particular medical condition, which can limit the generalizability of the results to the general population.
  7. Publication bias: There is a tendency for researchers to publish positive or negative results than inconclusive results. This leads to an over-representation of “findings” in the literature.
  8. Funding bias: Studies funded by industry stakeholders, such as pharmaceutical companies. This makes the study more likely to produce favourable results than studies funded by other sources. This ultimately creates a bias in the literature.
  9. Lack of transparency: Some studies on cannabis have been criticized for lack of transparency in their methods and results. This makes it challenging to evaluate the robustness of their findings.
  10. Prevalence of observational studies: There is a high prevalence of observational studies in cannabis research, which are prone to bias and confounding. They are less substantial than RCTs (randomized controlled trials) in determining causality.

This overreliance on observational studies means most cannabis research is false. Just as funding bias results in slogans like “Follow the Science,” which is ultimately synonymous with “Follow the Money.”

Studies Say” is the Modern Equivalent to, “The Scriptures Say…”

Most Cannabis Research is False

We’re not here to bash anyone’s spiritual beliefs. If you find solace in Holy Scripture, then all the best. But if you try and argue that your interpretation of the scriptures is describing a reality we all must follow, we’re going to have a problem.

Likewise, we won’t call out anyone using research studies to help navigate the world. You may be on a vegan diet and, therefore, like reading studies confirming the lifestyle’s benefits.

But, once you begin arguing with others that the vegan lifestyle is the only way to live, and you support these opinions by referring to “studies,” then it’s time to step back and reassess.

Both “scriptures” and “studies” express authority or provide evidence for a particular belief or claim.

Scriptures refer to religious texts or teachings considered sacred or authoritative by those who follow that faith. 

Studies, on the other hand, refer to scientific research findings. These are supposed to be based on empirical evidence and subject to rigorous testing, verification, and replication

The failure of much modern research, including cannabis research, to replicate findings is no small matter. That is why most cannabis research is false.

When you read: “Randomized controlled trials evaluating the therapeutic use and safety of marijuana are lacking, but a growing body of evidence suggests that marijuana consumption may be associated with adverse cardiovascular risks.”

You can roll your eyes. There is no “growing body of evidence” because, without RCTs, there is no evidence. Without replication, all you have is an opinion.





Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media